Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis

BACKGROUND: The clinical efficacy of rupatadine in terms of responders has not been previously explored in perennial allergic rhinitis (PAR). METHODS: This pooled analysis included data from 6 randomised, double-blind, placebo-controlled trials conducted in PAR patients treated with rupatadine 10 mg...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Allergy Asthma Clin Immunol
Main Authors: Valero, Antonio, Izquierdo, Iñaki, Kowalski, Marek L., Scadding, Glenis K., Bousquet, Jean, Mullol, Joaquim
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7181536/
https://ncbi.nlm.nih.gov/pubmed/32346387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-020-00425-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares